Literature DB >> 950575

The epidemiology of amyotrophic lateral sclerosis in Finland. A study based on the death certificates of 421 patients.

M Jokelainen.   

Abstract

The mortality and prevalence of ALS in the various countries of Finland was studied. The work was based on death certificates derived from a 10-year period from 1963 to 1972, and altogether 421 cases were found. The mean duration of the disease was 2.7 years, and the mean age at death was 61.2 years. The average annual mortality rate was 0.91 per 100,000. The male to female ratio was 0.87 to 1, males outnumbered females only in age groups under 65. Some clustering of the cases seems to be taking place in the south-eastern part of the country. The rural to urban distribution of the patients' places of birth and domiciles did not differ markedly from that of thw whole population. After ALS itself pneumonia was the most common direct cause of death. Of other significant conditions coded in the death certificates schizophrenia and cancer did not occur more often than could be expected by chance. No evidence of inheritance of the disease was found.

Entities:  

Mesh:

Year:  1976        PMID: 950575     DOI: 10.1016/0022-510x(76)90080-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

1.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

Review 2.  Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis.

Authors:  G C Román
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

3.  Remission of a syndrome indistinguishable from motor neurone disease after resection of bronchial carcinoma.

Authors:  D M Mitchell; S A Olczak
Journal:  Br Med J       Date:  1979-07-21

4.  Amyotrophic lateral sclerosis in the province of Parma, Italy: a clinical and epidemiological study in the period 1960-1980.

Authors:  G Juvarra; L Bettoni; E Bortone; A Garavelli; E Montanari; M Rocca
Journal:  Ital J Neurol Sci       Date:  1983-12

5.  Prognosis and clinical varieties of ALS disease.

Authors:  P Mortara; D Bardelli; M Leone; D Schiffer
Journal:  Ital J Neurol Sci       Date:  1981-08

6.  Motor neurone disease in the Lothian Region of Scotland 1961-81.

Authors:  S M Holloway; J D Mitchell
Journal:  J Epidemiol Community Health       Date:  1986-12       Impact factor: 3.710

7.  Motor neuron disease and malignancies: results of a population-based study.

Authors:  A Chiò; F Brignolio; P Meineri; M G Rosso; A Tribolo; D Schiffer
Journal:  J Neurol       Date:  1988-07       Impact factor: 4.849

8.  Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria.

Authors:  J D Mitchell; A C Gatrell; A Al-Hamad; R B Davies; G Batterby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

9.  Motor neuron disease in England and Wales, 1959-1979.

Authors:  J Buckley; C Warlow; P Smith; D Hilton-Jones; S Irvine; J R Tew
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

10.  Carcinoma of the prostate and motor neuron disease.

Authors:  C Boninsegna; M G Lovaste; G Ferrari
Journal:  Ital J Neurol Sci       Date:  1985-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.